April 27, 2023 Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
April 10, 2023 Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
March 7, 2023 Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types